Delisting of Securities of Evofem Biosciences, Inc.; Creatd Inc.; Molecular Data Inc.; ECMOHO Limited; and ALFI, Inc. from The Nasdaq Stock Market

Rhea-AI Summary

The Nasdaq Stock Market has announced the delisting of multiple companies due to their common stock suspensions. Evofem Biosciences was suspended on August 11, 2022; Creatd Inc. and Molecular Data Inc. were suspended on September 7, 2022; ECMOHO Limited was suspended on September 23, 2022; and ALFI, Inc. was suspended on October 25, 2022. The delistings are set to become effective ten days after filing a Form 25 with the SEC. For further information, stakeholders are encouraged to review public filings or contact the companies directly.

Positive

• None.

Negative

• Multiple companies, including Evofem Biosciences, Creatd Inc., Molecular Data Inc., ECMOHO Limited, and ALFI, Inc., face delisting from Nasdaq after extended trading suspensions, indicating potential financial instability.
• The suspension dates suggest the companies were unable to maintain compliance with Nasdaq listing standards, raising concerns for investors regarding future operations and stock recovery.

NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Evofem Biosciences, Inc.  Evofem Biosciences, Inc.’s common stock was suspended on August 11, 2022, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of Creatd Inc.  Creatd Inc.’s securities were suspended on September 7, 2022, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American Depositary Shares of Molecular Data Inc.  Molecular Data Inc.’s securities were suspended on September 7, 2022, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American Depositary Shares of ECMOHO Limited.  ECMOHO Limited’s securities were suspended on September 23, 2022, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of ALFI, Inc.  ALFI, Inc.’s securities were suspended on October 25, 2022, and have not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

-NDAQO-

FAQ

What companies are being delisted from Nasdaq?

The companies being delisted include Evofem Biosciences, Creatd Inc., Molecular Data Inc., ECMOHO Limited, and ALFI, Inc.

Why were these companies suspended from Nasdaq?

These companies were suspended due to non-compliance with Nasdaq's listing standards and have not traded since their respective suspension dates.

When will the delistings become effective?

The delistings will become effective ten days after Nasdaq files a Form 25 with the SEC.

What does suspension mean for these companies?

Suspension means that the companies' stocks are no longer traded on Nasdaq, indicating potential financial difficulties and risks for shareholders.

How can I find more information about the companies involved?

For more information, stakeholders should review the companies' public filings or contact them directly.